KPV for Skin: What the Evidence Shows
What human and animal studies show about KPV for skin, how strong that evidence is, and what is still unproven.
- Strongest evidence
- In vitro
- Human studies
- 1
- PubMed records, our ledger
- Animal studies
- 1
- PubMed records, our ledger
- Studies we summarised
- 3
- with an outcome for skin
Evidence for skin
Each row is an outcome related to skin from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.
| Outcome | Result | Study type | Source |
|---|---|---|---|
| Keratinocyte viability and IL-1beta | KPV at 50 ug/mL restored cell viability and reduced IL-1beta secretion in PM10-exposed keratinocytes. | In vitro (not a human result) | Tissue & cell 2025, PMID 40073467 |
| Skin permeation | KPV did not permeate human skin by passive diffusion alone (below the detection limit of 0.01 ug/mL); microneedles and iontophoresis were needed. | In vitro (not a human result) | Journal of pharmaceutical sciences 2017, PMID 28343991 |
| Cyclic AMP signalling | KPV did not raise cyclic AMP in human keratinocytes (mechanism study; no clinical outcome). | In vitro (not a human result) | The Journal of investigative dermatology 2004, PMID 15102092 |
PubMed records for KPV and skin: 1 human, 1 animal (search counts, not studies we reviewed). Grades follow our evidence scale.
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
Other peptides people research for skin
All peptides for skin, comparedCommon questions
Does KPV help with skin?
The strongest study we summarise for skin is in vitro evidence, across 3 studies with an outcome for skin. That is not proof it works in people.
Is KPV approved for skin?
No. KPV is not FDA approved for any use, including skin.
What is the best peptide for skin?
There is no single answer. Our skin overview compares each candidate by evidence grade and legal status rather than by popularity.
More on KPV
Sources
- 1Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.Tissue & cell · 2025PMID 40073467Accessed 2 Oct 2026
- 2Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.Journal of pharmaceutical sciences · 2017PMID 28343991Accessed 2 Oct 2026
- 3alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells.The Journal of investigative dermatology · 2004PMID 15102092Accessed 2 Oct 2026
Found an error? Report a correction.